Now showing items 14-33 of 59

• #### Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis ﻿

(Elsevier, 2015-02-26)
Background:To investigate potential cardiovascular and other effects of long-term pharmacological interleukin 1 (IL-1) inhibition, we studied genetic variants that produce inhibition of IL-1, a master regulator of ...
• #### Chronic disease research in Europe and the need for integrated population cohorts ﻿

The burden of chronic diseases in Europe is sure to increase in coming decades, due primarily to an aging European population. This will place an enormous burden on national health budgets that are already constrained and ...

(2017-07)
• #### Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease ﻿

(Massachusetts Medical Society, 2016-03-02)
BACKGROUND The discovery of low-frequency coding variants affecting the risk of coronary artery disease has facilitated the identification of therapeutic targets. METHODS Through DNA genotyping, we tested 54,003 ...
• #### Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease (vol 374, pg 1134, 2016) ﻿

(2016-05-12)

(2017-08)

(2016-09)
• #### Efficiency and safety of varying the frequency of whole blood donation: randomised trial of 45,000 donors ﻿

Background Limits on the frequency of whole blood donation exist primarily to safeguard donor health. However, there is substantial variation across blood services in the maximum frequency of donations allowed. We compared ...
• #### Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms ﻿

Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide. Although 58 genomic regions have been associated with CAD thus far, most of the heritability is unexplained, indicating that additional ...
• #### Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference. ﻿

(Springer Nature, 2018-02-19)
Detailed phenotyping is required to deepen our understanding of the biological mechanisms behind genetic associations. In addition, the impact of potentially modifiable risk factors on disease requires analytical frameworks ...
• #### The genetic architecture of type 2 diabetes. ﻿

(2016-08)
The genetic architecture of common traits, including the number, frequency, and effect sizes of inherited variants that contribute to individual risk, has been long debated. Genome-wide association studies have identified ...
• #### Genetic invalidation of Lp-PLA$_{2}$ as a therapeutic target: Large-scale study of five functional Lp-PLA$_{2}$-lowering alleles ﻿

(SAGE Publications Ltd, 2017-03-01)
$\textbf{Aims}$ Darapladib, a potent inhibitor of lipoprotein-associated phospholipase A$_{2}$ (Lp-PLA$_{2}$), has not reduced risk of cardiovascular disease outcomes in recent randomized trials. We aimed to test whether ...
• #### Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. ﻿

(2011-09-11)
• #### Genetically Determined Height and Coronary Artery Disease ﻿

(Massachusetts Medical Society, 2015-04-23)
The nature and underlying mechanisms of an inverse association between adult height and the risk of coronary artery disease (CAD) are unclear. Methods We used a genetic approach to investigate the association between height ...

(2016-10)
• #### Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. ﻿

(2018-01-17)
Vitamin D is a steroid hormone precursor that is associated with a range of human traits and diseases. Previous GWAS of serum 25-hydroxyvitamin D concentrations have identified four genome-wide significant loci (GC, ...

(2017-02)
• #### A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease ﻿

(American Association for the Advancement of Science, 2016-06-01)
Regulatory authorities have indicated that new drugs to treat type 2 diabetes (T2D) should not be associated with an unacceptable increase in cardiovascular risk. Human genetics may be able to guide development of antidiabetic ...
• #### Genomics of lipid metabolism: Identifying novel causal pathways and new therapeutic targets for reducing risk of coronary heart disease ﻿

(John Wiley & Sons Inc., 2016-09-28)
Coronary heart disease (CHD) is one of the leading causes of death worldwide; mortality rates are expected to continue to rise over the coming decades. Circulating lipids have been shown to be strongly and linearly associated ...
• #### Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity ﻿

(Nature Publishing Group, 2017-04-13)
A major goal of biomedicine is to understand the function of every gene in the human genome. Loss-of-function mutations can disrupt both copies of a given gene in humans and phenotypic analysis of such 'human knockouts' ...